Statera Biopharma, Inc. Announces Institutional Review Board Approves Study of STAT-205 for Acute COVID-19

NEXT STORY
Proactive MD selects health care industry leader Dr. Saria Saccocio as company president
PREV STORY
Locus Biosciences Secures Financing of up to $25 Million from Hercules Capital
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Vaxart to Provide 2021 Business Outlook on Tuesday, March 2, 2021

author_avatar
NASDAQ Market News

Global $77.6 Billion In Vitro Diagnostic (IVD) Reagents Market Forecast to 2027: Opportunities in the Growing Demand for Protein Therapeutics and Personalized Medicines

author_avatar
NASDAQ Market News

atai Life Sciences launches TryptageniX to further expand atai’s robust intellectual property portfolio and strengthen atai’s supply chain

author_avatar
NASDAQ Market News